SOPH
SOPH
NASDAQ · Health Care

Sophia Genetics Sa

$6.93
+0.24 (+3.59%)
As of Aug 8, 2:00 AM ET ·
Financial Highlights (FY 2026)
Revenue
106.79M
Net Income
-109,177,478
Gross Margin
67.4%
Profit Margin
-102.2%
Rev Growth
+17.6%
D/E Ratio
1.34
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 67.4% 67.4% 37.1% 37.1%
Operating Margin -91.8% -82.6% 15.7% 15.5%
Profit Margin -102.2% -97.1% 12.0% 14.7%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 106.79M 90.84M 148.95M 128.31M
Gross Profit 71.98M 61.22M 55.31M 47.64M
Operating Income -97,988,691 -75,016,861 23.40M 19.86M
Net Income -109,177,478 -83,582,621 17.87M 18.85M
Gross Margin 67.4% 67.4% 37.1% 37.1%
Operating Margin -91.8% -82.6% 15.7% 15.5%
Profit Margin -102.2% -97.1% 12.0% 14.7%
Rev Growth +17.6% +17.6% -3.7% -9.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 185.01M 185.01M 123.79M 131.89M
Total Equity 138.41M 138.41M 159.52M 160.29M
D/E Ratio 1.34 1.34 0.78 0.82
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -92,497,975 -74,747,427 34.80M 29.87M
Free Cash Flow 26.94M 20.01M